• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
AS20000007 白喉-破伤风-无细胞百日咳、灭活脊髓灰质炎和b型流 Other Biological Products Import Drug Application 2000-01-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2005-08-11 view
HS20010006 麻疹、腮腺炎、风疹活疫苗 Lyophilized Biological Products Import Drug Application 2001-06-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-08-07 view
HS20010020 流行性感冒灭活疫苗 Injection Biological Products Import Drug Application 2002-02-06 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-06-19 view
H20000347 泛昔洛韦 famciclovir Active ingredient Chemical Drugs Import Drug Application 2001-02-26 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-05-24 view
H20010141 阿莫西林/克拉维酸钾片 Amoxicillin;Potassium Clavulanate Tablet Chemical Drugs Import Drug Application 2001-07-10 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-05-08 view
AS20000030 Vi多糖伤寒疫疫苗 Other Biological Products New Drug Application 2000-10-31 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2001-10-29 view
A20000035 消旋卡多曲颗粒剂 racecadotril Granule Chemical Drugs Import Drug Application 2000-01-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review view
BS20010007 麻疹、腮腺炎、风疹活疫苗 Lyophilized Biological Products Import Drug Application 2001-04-17 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated view
B20000175 盐酸托泊替康 topotecan hydrochloride Active ingredient Chemical Drugs Import Drug Application 2001-02-26 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated view